ReviewMediastinum (Hong Kong, China)2026
Narrative review of descending necrotizing mediastinitis, focusing on the etiology, classification-guided surgical management, treatments, and prognosis.
Review in Mediastinum (Hong Kong, China), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Objective: Descending necrotizing mediastinitis (DNM) is a rare, life-threatening infection characterized by the rapid spread of deep neck infection (DNI) along the continuous fascial planes into the mediastinum. Although diagnostic and therapeutic advances have improved patient outcomes, the prognosis remains unsatisfactory in advanced cases or in the absence of timely and appropriate treatment, mainly due to delayed diagnoses and difficulty in selecting an appropriate surgical approach. This review summarizes the current knowledge on the pathophysiology, anatomical classification, and surgical treatment of DNM, with particular emphasis on a recently proposed classification for surgical planning. Methods: A literature search was conducted using PubMed/MEDLINE for the period from January 1999 to June 2025 with the term "descending necrotizing mediastinitis". Full texts were retrieved through the Oita University Library. No restrictions were placed on article type. Eligible studies were English-language reports (written in English at least in abstract) addressing the etiology, pathophysiology, anatomical classification, surgical approach and treatment, or outcome of DNM. Conference proceedings and animal experimental studies were excluded. For quantitative tabulations, only articles reporting ≥4 patients were included, and less than 4 patients case-reports were excluded from the quantitative summaries. Key Content and Findings: Over time, disease classification has become more common, and the proportion of Type I disease has been increasing, reflecting improvements in the early diagnosis. Mortality rates have improved from 24.7% in the 2000s to 17.8% in the 2010s and to 14.1% in the 2020s, in our descriptive rates derived from registry cohorts. Type II disease extending below the carina, is associated with worse outcomes than Type I disease. In particular, Type IIC disease descending through the retrovisceral space, is often unsuitable for traditional anterior approaches and requires a posterior mediastinal approach via video-assisted thoracic surgery (VATS). Optimal outcomes depend on a multidisciplinary treatment strategy that includes early airway management, broad-spectrum antimicrobial therapy, and precise targeted surgical drainage. Conclusions: Improved treatment outcomes for DNM require a rapid diagnosis, accurate anatomical assessment, and prompt, case-appropriate surgical intervention. Recognizing the correct classification enables the selection of the most suitable drainage approach and is expected to further improve the prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.